|
Large language models for precision oncology: Clinical decision support through expert-guided learning. |
|
|
(OPTIONAL) Uncompensated Relationships - Roche |
|
|
No Relationships to Disclose |
|
|
|
|
|
Honoraria - BMS GmbH & Co. KG |
Travel, Accommodations, Expenses - BeiGene; SOBI |
|
|
Honoraria - Falk Foundation; iOMEDICO; Janssen-Cilag; MSD; Need |
|
|
|
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Janssen; MSD |
Speakers' Bureau - AstraZeneca; Bayer; BMS GmbH & Co. KG; Illumina; MSD; Personal Genome Diagnostics; QuiP |
Travel, Accommodations, Expenses - AstraZeneca; Illumina; Personal Genome Diagnostics |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - AIM GmbH; Therawis |
Honoraria - AstraZeneca; Biermann Press; Celgene; GlaxoSmithKline; Lilly; Myriad Genetics; Springer; Teva |
Consulting or Advisory Role - DKMS; Exeltis; Myriad Genetics; Teva |
Research Funding - Sphingotec |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - ALK-Abello |
(OPTIONAL) Uncompensated Relationships - DIGITALWERK AOK Baden-Württemberg |
|
|
Consulting or Advisory Role - BMS GmbH & Co. KG |
Speakers' Bureau - AstraZeneca; BMS GmbH & Co. KG; Janssen |
Research Funding - BMS GmbH & Co. KG |
Travel, Accommodations, Expenses - BMS GmbH & Co. KG |
|
|
Stock and Other Ownership Interests - AstraZeneca; Pfizer; Swedish Orphan Biovitrum |
Research Funding - Lilly (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |